Loading market dashboard

Financials in USD. Standardized financial statements.
A compact view of how Pulse Biosciences, Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $350,000 | $0 | $0 | $700,000 | $1.42M | $0 | $0 | $0 | $0 | $0 |
| Revenue Growth? | 0.0% | 0.0% | -100.0% | -50.6% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Cost of Revenue? | $1.61M | $0 | $1.21M | $11.94M | $1.97M | $1.09M | $666,000 | $665,000 | $665,000 | $665,000 |
| Gross Profit? | -$1.26M | $0 | -$1.21M | -$11.24M | -$550,000 | -$1.09M | -$666,000 | -$665,000 | -$665,000 | -$665,000 |
| Gross Margin? | -360.0% | 0.0% | 0.0% | -1606.3% | -38.8% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Expenses? | $75.68M | $56.26M | $42.37M | $46.81M | $62.46M | $48.87M | $47.95M | $37.96M | $25.81M | $9.59M |
| Operating Income? | -$76.94M | -$56.26M | -$43.57M | -$58.06M | -$63.01M | -$49.97M | -$47.95M | -$37.96M | -$25.81M | -$9.59M |
| EBITDA? | -$71.71M | -$55.08M | -$42.37M | -$56.70M | -$61.87M | -$48.87M | -$46.79M | -$36.65M | -$24.57M | -$8.83M |
| Income Before Tax | -$72.78M | -$53.59M | -$42.21M | -$58.51M | -$63.66M | -$49.85M | -$46.97M | -$37.55M | -$25.57M | -$9.52M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$28,000 | $0 | -$94,000 |
| Net Income? | -$72.78M | -$53.59M | -$42.21M | -$58.51M | -$63.66M | -$49.74M | -$45.99M | -$37.55M | -$25.57M | -$9.52M |
| EPS? | $-1.08 | $-0.92 | $-0.88 | $-1.72 | $-2.28 | $-2.14 | $-2.22 | $-2.20 | $-1.73 | $-0.86 |
| Diluted EPS? | $-1.08 | $-0.92 | $-0.88 | $-1.72 | $-2.28 | $-2.14 | $-2.22 | $-2.20 | $-1.73 | $-0.86 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality